Q. Liao

发表

Dual targeting powder formulation of antiviral agent for customizable nasal and lung deposition profile through single intranasal administration

Shuofeng Yuan, J. Lam, S. Leung, 2022, International Journal of Pharmaceutics.

Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition

Michael Y. T. Chow, J. Lam, H. Chan, 2019, International journal of pharmaceutics.

Nanoporous mannitol carrier prepared by non-organic solvent spray drying technique to enhance the aerosolization performance for dry powder inhalation

Chuan-Yu Wu, J. Xu, Ying Huang, 2017, Scientific Reports.

High siRNA loading powder for inhalation prepared by co-spray drying with human serum albumin.

Michael Y. T. Chow, J. Lam, H. Chan, 2019, International journal of pharmaceutics.

Combined one-stage minimally invasive surgery for primary pulmonary carcinoma and mitral regurgitation

Chao Yang, Xiaoshen Zhang, Chengfeng Huang, 2020, Journal of Cardiothoracic Surgery.

Effective mRNA pulmonary delivery by dry powder formulation of PEGylated synthetic KL4 peptide.

Michael Y. T. Chow, J. Lam, Yingshan Qiu, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Inhaled Dry Powder Formulation of Tamibarotene, a Broad‐Spectrum Antiviral against Respiratory Viruses Including SARS‐CoV‐2 and Influenza Virus

J. Chan, K. Yuen, Shuofeng Yuan, 2021, Advanced Therapeutics.

Effect of formulation and inhaler parameters on the dispersion of spray freeze dried voriconazole particles.

J. Lam, P. Kwok, Q. Liao, 2020, International journal of pharmaceutics.

Spray-Dried Powder Formulation of Capreomycin Designed for Inhaled Tuberculosis Therapy

Michael Y. T. Chow, J. Lam, P. Kwok, 2021, Pharmaceutics.

Intratracheal Administration of Dry Powder Formulation in Mice.

J. Lam, Q. Liao, Y. Qiu, 2020, Journal of Visualized Experiments.

Inhaled Antifungal Agents for the Treatment and Prophylaxis of Pulmonary Mycoses.

J. Lam, Q. Liao, 2021, Current pharmaceutical design.